Skip to main content

In Vivo Drug Discovery Platforms for Amyotrophic Lateral Sclerosis

Published Date

Designing and validating mouse models for the study of Amyotrophic Lateral Sclerosis (ALS) and other neuromuscular diseases presents a unique set of challenges. The JAX In Vivo Pharmacology Services team has validated and routinely employs five robust ALS mouse models to support drug discovery.

Join us to review:
- phenotypic characteristics and considerations for selecting therapeutically relevant ALS models
- sample study designs and experimental readouts to evaluate the efficacy of candidate molecules to treat ALS